DeepScribe, the industry-leading ambient AI for oncology care, has been selected by CARTI, one of the nation’s premier independent cancer care providers, to power documentation and real-time intelligence for CARTI clinicians across its 18 locations. The partnership seamlessly integrates DeepScribe’s oncology-specific ambient AI into the CARTI workflow.
“DeepScribe is designed to support clinicians in connecting with and caring for patients,” said Matthew Ko, DeepScribe CEO and Co-founder. “This partnership eliminates the weight of documentation for CARTI oncologists, and gives them the insights and room to cultivate those connections with patients – that’s at the heart of care. We’re excited to help the CARTI team make the most of every encounter.”
Beyond documentation, the DeepScribe Ambient Operating System delivers insights such as HCC risk capture guidance and E/M coding recommendations, further reducing administrative burden and helping oncologists concentrate entirely on patient care. Not only can CARTI clinicians spend less time charting, they can also gain insights that enhance clinical decision-making and streamline care delivery.
Also Read: Biostate AI & ACP Partner on MS AI Model Project
“Our mission at CARTI is making trusted cancer care accessible for every patient we serve through compassion, innovation, and purpose,” said Carson Seelinger, Chief Information Officer at CARTI. “By partnering with DeepScribe, we are empowering our clinicians with AI technology from a company that understands oncology. This collaboration allows our teams to continue to focus on what matters most – our patients – while enhancing our ability to make a meaningful impact across Arkansas.”
CARTI clinicians will also benefit from DeepScribe’s deep, seamless integration with Flatiron Health’s OncoEMR®. With DeepScribe as Flatiron’s ambient AI partner, the technical integration goes well beyond pushing discrete notes and synchronizing schedules – it applies a contextual awareness of each patient’s history to enhance the quality, accuracy, and relevance of documentation and clinical intelligence.
DeepScribe’s oncology leadership comes from years of AI refinement and collaboration with industry leaders. The result is oncology-specific workflows, context-aware documentation, terminology expertise – technology designed for one of medicine’s most complex specialties.
“As a documentation tool, DeepScribe is bringing immediate, meaningful improvements to clinicians’ daily lives,” said Dean Dalili, MD, MHCM, DeepScribe’s Chief Medical Officer. “But the value of DeepScribe extends beyond a day’s worth of patient visits. Each recorded point-of-care interaction becomes the source for data insights and longitudinal intelligence. For organizations like CARTI, this can offer value long beyond clinical notes, supporting better patient care and informed decision-making at every turn.”
Source: PRNewswire
